Lane Generational’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.43M Buy
486,849
+146,242
+43% +$1.85M 3.53% 9
2025
Q4
$4.66M Buy
340,607
+28,722
+9% +$532K 4.22% 8
2025
Q3
$6.8M Buy
311,885
+53,458
+21% +$630K 5.64% 6
2025
Q2
$3.09M Buy
258,427
+16,382
+7% +$206K 2.88% 17
2025
Q1
$2.88M Buy
242,045
+84,350
+53% +$1.31M 3.27% 14
2024
Q4
$2.43M Hold
157,695
2.37% 18
2024
Q3
$1.77M Sell
157,695
-11,822
-7% -$113K 2.2% 17
2024
Q2
$914K Sell
169,517
-5,115
-3% -$29.6K 1.08% 22
2024
Q1
$1.19M Buy
174,632
+341
+0.2% +$2.38K 1.4% 20
2023
Q4
$1.18M Buy
174,291
+24,512
+16% +$139K 1.47% 19
2023
Q3
$750K Buy
149,779
+103,019
+220% +$613K 0.93% 23
2023
Q2
$339K Buy
+46,760
New +$398K 0.49% 28

Other funds holding CLPT

Lane Generational's CLPT Position: Q1 2026 in Review

Lane Generational increased its ClearPoint Neuro (CLPT) stake by 43% in Q1 2026, buying an estimated $1.85M and bringing the position to 486,849 shares worth $4.43M. The position accounts for 3.53% of the portfolio, ranked #9.

Lane Generational first reported a position in CLPT in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.8M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Lane Generational held 486,849 shares of ClearPoint Neuro worth $4.43M as of Q1 2026.
  • Lane Generational bought 146,242 ClearPoint Neuro shares in Q1 2026, an estimated $1.85M.
  • ClearPoint Neuro made up 3.53% of Lane Generational's portfolio in Q1 2026, its #9 holding.
  • Lane Generational first reported a position in ClearPoint Neuro in Q2 2023 and has held it in 12 quarters since.
  • Lane Generational's ClearPoint Neuro position peaked at $6.8M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Lane Generational's 13F filing for Q1 2026, filed 14 May 2026.